Two persons diagnosed with cancer treated with robotic surgeries

A 14-year-old boy and 53-year-old man from Bangladesh underwent robotic surgeries at Apollo Proton Cancer Centre

July 25, 2022 06:32 pm | Updated 07:26 pm IST - CHENNAI

Harshad Reddy Director-Operations, Group Oncology and International, Apollo Proton Cancer Centre; Rakesh Jalali, Medical Director; and Harish Trivedi, Chief Executive Officer, Apollo Proton Cancer Centre; addressing a press meet in Chennai on Monday.

Harshad Reddy Director-Operations, Group Oncology and International, Apollo Proton Cancer Centre; Rakesh Jalali, Medical Director; and Harish Trivedi, Chief Executive Officer, Apollo Proton Cancer Centre; addressing a press meet in Chennai on Monday. | Photo Credit: M. KARUNAKARAN

A 14-year-old boy diagnosed with a tumour in the trachea and a 53-year-old man with dual cancer underwent robotic surgeries in a private hospital.

In the first case, the boy from Bangladesh presented with acute respiratory distress and was diagnosed with a tumour in the trachea, which is the windpipe. This was blocking the right side of the bronchus. He was operated in his country during which a small portion of the tumour was removed, Rakesh Jalali, medical director and lead, Neuro Oncology, Apollo Proton Cancer Centre (APCC), told reporters on Monday.

At APCC, the thoracic cancer management team evaluated him and found a large tumour blocking the bronchus, and it was difficult to operate on, he said. The patient underwent robotic-assisted tracheal resection and reconstruction along with mediastinal nodal dissection. There was complete removal of the tumour and the boy recovered steadily.

In the second case, the man, who was from Bangladesh, had two myocardial infarctions and had an angioplasty done in March. He complained of bleeding per rectum with haemoglobin of four. He was diagnosed with a large cancer in the colon and another one in the thyroid.

Considering his history of heart attack, a minimal access and quick procedure was necessity as anaesthesia could pose a significant risk, he said and added that he was treated with a robotic radical right hemicolectomy and conventional right hemithyoidectomy by the surgical oncologist and robotic surgeon team.

Harshad Reddy, director-Operations, Group Oncology and International, APCC and Harish Trivedi, chief executive officer, APCC, spoke.

0 / 0
Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products
Sign in

Comments

Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.